XTRA:EVTLife Sciences
Is Evotec (XTRA:EVT) Quietly Redefining Its Operating Model With Horizon And A New COO?
Evotec SE has reported its 2025 results with sales of €788.37 million and a reduced net loss of €103.52 million, while also progressing its Horizon restructuring initiative and confirming the planned end of Supervisory Board Chairwoman Prof. Dr. Iris Löw-Friedrich’s term in June 2026.
Alongside these changes, the company has appointed Dr. Ingrid Müller as Chief Operating Officer from May 2026 to steer global operations and the Horizon program, highlighting a push to tighten execution and...